ConductScience.org, home

Paper37726484

SARS-CoV-2 antibodies recognize 23 distinct epitopic sites on the receptor binding domain.

Jiang J and 6 others. Commun Biol, 2023. Cited by 24 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. SARS-CoV-2 antibodies recognize 23 distinct epitopic sites on the receptor binding domain. Papers, record 37726484. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37726484

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
SARS-CoV-2 antibodies recognize 23 distinct epitopic sites on the receptor binding domain.
PubMed
Journal
Commun Biol
PubMed
Year
2023
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
24
iCite
Relative citation ratio, by iCite
1.79
iCite
Revised in PubMed
2026-01-27
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Jiang JJianshenghttps://orcid.org/0000-0003-0964-5481
2Boughter CTChristopher Thttps://orcid.org/0000-0002-7106-4699
3Ahmad JJaveed
4Natarajan KKannanhttps://orcid.org/0000-0002-6295-2571
5Boyd LFLisa F
6Meier-Schellersheim MMartinhttps://orcid.org/0000-0002-8754-6377
7Margulies DHDavid Hhttps://orcid.org/0000-0001-8530-7375

Source PubMed

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
PandemicsMajor topic
COVID-19Major topic
Humans
SARS-CoV-2
Antibodies, Viral
Spike Glycoprotein, Coronavirus
Fluprednisolone

Source PubMed

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Update of37,333,174

Source PubMed

References72

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135,772,405Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum.Cell2022https://conductscience.org/library/papers/35772405PubMed
235,438,546An antibody class with a common CDRH3 motif broadly neutralizes sarbecoviruses.Sci Transl Med2022https://conductscience.org/library/papers/35438546PubMed
334,537,245Structures of synthetic nanobody-SARS-CoV-2 receptor-binding domain complexes reveal distinct sites of interaction.J Biol Chem2021https://conductscience.org/library/papers/34537245PubMed
433,169,668Biochemical patterns of antibody polyreactivity revealed through a bioinformatics-based analysis of CDR loops.Elife2020https://conductscience.org/library/papers/33169668PubMed
533,756,110The antigenic anatomy of SARS-CoV-2 receptor binding domain.Cell2021https://conductscience.org/library/papers/33756110PubMed
632,225,175Structural basis of receptor recognition by SARS-CoV-2.Nature2020https://conductscience.org/library/papers/32225175PubMed
734,554,826Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium study.Science2021https://conductscience.org/library/papers/34554826PubMed
826,193,119Contacts-based prediction of binding affinity in protein-protein complexes.Elife2015https://conductscience.org/library/papers/26193119PubMed
934,244,522Potent and protective IGHV3-53/3-66 public antibodies and their shared escape mutant on the spike of SARS-CoV-2.Nat Commun2021https://conductscience.org/library/papers/34244522PubMed
105,551,392The interpretation of protein structures: estimation of static accessibility.J Mol Biol1971https://conductscience.org/library/papers/5551392PubMed
112,687,698Conformations of immunoglobulin hypervariable regions.Nature1989https://conductscience.org/library/papers/2687698PubMed
1232,661,058Structural basis of a shared antibody response to SARS-CoV-2.Science2020https://conductscience.org/library/papers/32661058PubMed
1336,085,335Arsenal of nanobodies shows broad-spectrum neutralization against SARS-CoV-2 variants of concern in vitro and in vivo in hamster models.Commun Biol2022https://conductscience.org/library/papers/36085335PubMed
1437,261,904Modeling of ACE2 and antibodies bound to SARS-CoV-2 provides insights into infectivity and immune evasion.JCI Insight2023https://conductscience.org/library/papers/37261904PubMed
152,454,644Three-dimensional structure of antibodies.Annu Rev Immunol1988https://conductscience.org/library/papers/2454644PubMed
1628,588,190An optimal distance cutoff for contact-based Protein Structure Networks using side-chain centers of mass.Sci Rep2017https://conductscience.org/library/papers/28588190PubMed
1736,535,326Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution.Nature2023https://conductscience.org/library/papers/36535326PubMed
1834,155,209Sequence signatures of two public antibody clonotypes that bind SARS-CoV-2 receptor binding domain.Nat Commun2021https://conductscience.org/library/papers/34155209PubMed
1937,023,193Germline-encoded amino acid-binding motifs drive immunodominant public antibody responses.Science2023https://conductscience.org/library/papers/37023193PubMed
2035,412,617Search and sequence analysis tools services from EMBL-EBI in 2022.Nucleic Acids Res2022https://conductscience.org/library/papers/35412617PubMed

See all 72 references

Cited by21

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.

PMIDTitleJournalYearIn PapersSource
42,943,361Computational Assessment of CKP-25 Binding at Receptor-Recognition Interfaces Across Diverse Human Coronaviruses.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42943361PubMed
42,538,972
Localized Rigidification and Allosteric Modulation Mechanisms of SARS-CoV-2 Spike Neutralization by Class 3 and Class 4 Antibodies at Atomic Resolution: An Integrated Computational Study of Binding, Dynamics, and Allostery.
bioRxiv2026https://conductscience.org/library/papers/42538972PubMed
42,123,600
Mechanisms of Binding and Immune Escape Resistance for Broadly Neutralizing Antibodies Targeting Distinct Conserved SARS-CoV-2 Spike Epitopes: A Hierarchical Approach Integrating Mutational Profiling and Energy Landscape Analysis.
Int J Mol Sci2026https://conductscience.org/library/papers/42123600PubMed
41,959,354Frustration Landscapes of Broadly Neutralizing SARS-CoV-2 Spike Antibodies Targeting Conserved Epitopes Reveal Energetic Logic of Escape-Proof and Escape-Prone Mechanisms.bioRxiv2026https://conductscience.org/library/papers/41959354PubMed
41,629,525Structural mechanism of anti-MHC-I antibody blocking of inhibitory NK cell receptors in tumor immunity.Commun Biol2026https://conductscience.org/library/papers/41629525PubMed
41,542,366CoV-UniBind: a unified antibody binding database for SARS-CoV-2.Bioinform Adv2026https://conductscience.org/library/papers/41542366PubMed
41,333,432Structural mechanism of anti-MHC-I antibody blocking of inhibitory NK cell receptors in tumor immunity.Res Sq2025https://conductscience.org/library/papers/41333432PubMed
41,309,056Isolation of neutralizing antibodies against SARS-CoV-2 through an epitope-guided negative screening by phage display.J Biomed Res2026https://conductscience.org/library/papers/41309056PubMed
41,217,174Design of antibody structure-guided epitope vaccines in silico to induce potent immune responses against emerging viruses.J Virol2025https://conductscience.org/library/papers/41217174PubMed
41,117,360A unified topology-based classification of SARS-CoV-2 RBD neutralizing antibodies systematizes affinity trends across variants.MAbs2025https://conductscience.org/library/papers/41117360PubMed
41,085,626Utilizing Protein Bioinformatics to Delve Deeper into Immunopeptidomic Datasets with AIMS: An Automated Immune Molecule Separator.Methods Mol Biol2026https://conductscience.org/library/papers/41085626PubMed
41,077,783Rapid immunization and antibody redesign platform discovers broadly neutralizing antibodies against non-immunized SARS-CoV-2 variant.Mol Ther2026https://conductscience.org/library/papers/41077783PubMed
40,895,570From immune evasion to broad in silico binding: computational optimization of SARS-CoV-2 RBD-targeting nanobody.Front Immunol2025https://conductscience.org/library/papers/40895570PubMed
40,659,740An iterative strategy to design 4-1BB agonist nanobodies de novo with generative AI models.Sci Rep2025https://conductscience.org/library/papers/40659740PubMed
40,593,431B Cell Epitope Mapping by High-Density Competition ELISAs.Methods Mol Biol2025https://conductscience.org/library/papers/40593431PubMed
39,556,615Profiling serum immunodominance following SARS-CoV-2 primary and breakthrough infection reveals distinct variant-specific epitope usage and immune imprinting.PLoS Pathog2024https://conductscience.org/library/papers/39556615PubMed
39,463,836Engineering a SARS-CoV-2 Vaccine Targeting the Receptor-Binding Domain Cryptic-Face via Immunofocusing.ACS Cent Sci2024https://conductscience.org/library/papers/39463836PubMed
39,100,673A potent, broadly neutralizing human monoclonal antibody that efficiently protects hACE2-transgenic mice from infection with the Wuhan, BA.5, and XBB.1.5 SARS-CoV-2 variants.Front Immunol2024https://conductscience.org/library/papers/39100673PubMed
38,470,113Single-domain antibodies reveal unique borrelicidal epitopes on the Lyme disease vaccine antigen, outer surface protein A (OspA).Infect Immun2024https://conductscience.org/library/papers/38470113PubMed
38,456,672Experimental Structures of Antibody/MHC-I Complexes Reveal Details of Epitopes Overlooked by Computational Prediction.J Immunol2024https://conductscience.org/library/papers/38456672PubMed

See all 21 cited by

Genes9

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ABL125PubTator's text mininghttps://conductscience.org/library/genes/25NCBI Gene
ACE259,272PubTator's text mininghttps://conductscience.org/library/genes/59272NCBI Gene
ALKBH18,846PubTator's text mininghttps://conductscience.org/library/genes/8846NCBI Gene
ESS28,220PubTator's text mininghttps://conductscience.org/library/genes/8220NCBI Gene
F52,153PubTator's text mininghttps://conductscience.org/library/genes/2153NCBI Gene
IGH3,492PubTator's text mininghttps://conductscience.org/library/genes/3492NCBI Gene
IGHJ628,475PubTator's text mininghttps://conductscience.org/library/genes/28475NCBI Gene
IGHV3-5328,420PubTator's text mininghttps://conductscience.org/library/genes/28420NCBI Gene
IGHV3-6628,412PubTator's text mininghttps://conductscience.org/library/genes/28412NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37726484

GET https://conductscience.org/api/papers/v1/37726484/references?page=2